Low bone density with the use of valproate [4]

General Hospital Psychiatry

Volumn 27, Issue 5, 2005, Pages 376-378

  Waheed, Ayesha ^a   Kettl, Paul A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID;

ADULT; BEHAVIOR; BONE DENSITY; BONE DISEASE; BONE MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; LETTER; LIFESTYLE; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; OSTEOPOROSIS; PSYCHIATRY;

ANTICONVULSANTS; BONE DENSITY; FEMALE; HUMANS; MALE; MIDDLE AGED; VALPROIC ACID;

EID: 24944535319     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2005.03.008     Document Type: Letter

References (14)

1. D.L. Andress, J. Ozuna, and D. Tirschwell Antiepileptic drug-induced bone loss in young male patients who have seizures Arch Neurol 59 5 2002 781 786
2. Y. Sato, I. Kondo, and S. Ishida Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy Neurology 57 3 2001 445 449
3. R.D. Sheth, C.A. Wesolowski, and J.C. Jacob Effect of carbamazepine and valproate on bone mineral density J Pediatr 127 2 1995 256 262
4. A. Boluk, M. Guzelipek, and H. Savh The effect of valproate on bone mineral density in adult epileptic patients Phamacol Res 50 1 2004 93 97
5. J. McGuire, V. Baram, and J. Asher Osteopenia associated with divalproex sodium J Clin Psychopharmacol 24 3 2004 357 358
6. U. Halbreich, and S. Palter Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes Schizophr Bull 22 3 1996 447 454
7. H. Tsukahara, K. Kimura, and Y. Todoroko Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy Pediatr Int 44 2002 247 253
8. N. Oner, M. Kaya, and S. Karasalihoglu Bone mineral metabolism changes in epileptic children receiving valproic acid J Paediatr Child Health 40 8 2004 470 473
9. A.M. Pack, and M.J. Morrell Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications CNS Drugs 15 8 2001 633 642
10. A.B. Emiliano, and J.L. Fudge From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions Neuropsychopharmacology 29 5 2004 833 846
11. G. Abraham, W.W. Paing, J. Kaminski, A. Joseph, E. Kohegyi, and R.C. Josiassen Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study Am J Psychiatry 160 9 2003 1618 1620
12. B.M. Biller, H.B. Baum, D.I. Rosenthal, V.C. Saxe, P.M. Charpie, and A. Klibanski Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea J Clin Endocrinol Metab 75 3 1992 692 697
13. C. Di Somma, A. Colao, and A. Di Sarno Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males J Clin Endocrinol Metab 83 3 1998 807 813
14. A. Waheed, and P. Kettl Osteoporosis prevention, diagnosis, and therapy NIH Consens Statement (Online) 17 1 2000 1 36